You are here:

conestat (Ruconest)

Advice

in the absence of a submission from the holder of the marketing authorisation

conestat alfa (Ruconest®) is not recommended for use within NHS Scotland.

Indication: treatment of acute angioedema attacks in adults with hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.
 

Drug Details

Drug Name: conestat (Ruconest)
SMC Drug ID: 745/11
Indication: Treatment of acute angioedema attacks in adults with hereditary angioedema (HAE)
BNF Category:
Sub Category: 3.4 Antihistamines hyposensitisation and allergic emergencies
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 10 October 2011

Back